Life SciencesRSS

  • August 29, 2007

    Seroquel Judge Sets Homework For AstraZeneca

    The judge overseeing product liability litigation against AstraZeneca's blockbuster Seroquel will not consider calls to dismiss certain strict liability claims from the consolidated cases until the pharmaceutical giant offers up a detailed argument.

  • August 29, 2007

    Northwest Sued Over Cancer Vaccine Claim

    Northwest Biotherapeutics, which saw its share price more than double after the biotechnology company announced approval of the world’s first brain cancer vaccine, faces two purported securities class actions for allegedly deceiving investors with misleading statements.

  • August 30, 2007

    Boston Scientific's Trade Claim Tossed In Ev3 Feud

    Marking the latest development in Boston Scientific Corp.'s patent infringement feud with ev3 Inc. over embolic protection devices, a federal judge has agreed with a magistrate judge's recommendation that the medical device maker's trade secret claim against its rival should be dismissed for lack of subject matter jurisdiction.

  • August 28, 2007

    Boston Scientific Loses Bid To Toss ERISA Suit

    A federal court judge has denied Boston Scientific Corp.'s motions to toss a putative class action filed by employees who claim the medical device maker breached its fiduciary duty to administer and watch over their retirement benefits.

  • August 31, 2007

    Nixon Peabody

    What makes a top company pick up the phone and call on the product liability practice group at Nixon Peabody LLP when it's got an important issue to deal with? According to Joseph Ortego, the firm's national practice group leader, the reason is simple: a high success rate at trial.

  • August 28, 2007

    Judge Tosses More Plaintiffs From Celebrex Case

    Yet more plaintiffs have been dismissed from the massive product liability litigation over pharmaceutical giant Pfizer Inc.'s controversial anti-inflammatory drugs Bextra and Celebrex.

  • August 28, 2007

    Aredia Patients Push For Dental Monitoring Class

    Seeking to open another front in the war against Novartis Pharmaceuticals Corp., a second group of plaintiffs has asked to be certified as a class in the Aredia and Zometa product liability litigation. These plaintiffs, who might be at risk, want to be monitored for the jaw deterioration the drugs allegedly cause.

  • August 28, 2007

    Goldman Sachs Worker Admits Insider Trading

    A former Goldman Sachs Group associate has pled guilty to his role in a massive insider trading ring, admitting he traded on tips from a grand juror, two printing plant workers and a former financial analyst who leaked him details on big mergers, including drug giant Novartis AG's takeover of Eon Labs.

  • August 29, 2007

    Apotex Defends Declaration In Acular Patent Suit

    Apotex Inc. has asserted that a key declaration by a doctor bolsters its opposition to Allergan Inc.’s bid for summary judgment, which alleges the Canadian generic drug maker infringed a patent for Acular when Apotex submitted an application for a generic copy of the itchy eye treatment.

  • August 27, 2007

    Align Declares Victory In Orthodontic Patent Case

    A federal appeals court panel has, for the most part, upheld a lower court ruling that four Ormco Corp. patents were invalid and therefore not infringed by rival orthodontic maker Align Technology Inc.

  • August 27, 2007

    Judge Approves Breast Implant Maker's Asset Auction

    Bankrupt breast implant maker MediCor Ltd. has won court approval to sell its assets and the assets of some of its nondebtor subsidiaries.

  • August 27, 2007

    FDA To Study Television Drug Ads

    A new government study will examine whether positive visuals in television drug advertisements interfere with the way viewers process potential side effects.

  • August 27, 2007

    Celgene Sues Barr Over Generic Thalomid

    Celgene Corp. has filed another patent suit against Barr Pharmaceuticals Inc. in an attempt to stave off generic competition for its lucrative cancer treatment Thalomid, which brought in $117.7 million in net sales in the second quarter of 2007.

  • August 27, 2007

    Judge Throws Novartis Suit Out Of Federal Court

    Despite the protests of Novartis Pharmaceuticals Corp., a federal district judge has granted the request of two plaintiffs to remand their case to state court, sending the suit back to the lower court as the product liability litigation over bone cancer drugs Aredia and Zometa continues to unfold.

  • August 24, 2007

    Abbott Fights Order Allowing Shared Discovery

    Abbott Laboratories Inc. has lashed out at a judge's order allowing a plaintiff in the average wholesale price litigation to share discovery from other state cases against the drug maker with government prosecutors, arguing that the information has “nothing to do with the claims” in the multidistrict action.

  • August 24, 2007

    Nellson's Creditors Seal $153.5M Buyout Deal

    A federal bankruptcy judge has given the green light to a buyout deal that will see creditors of Nellson Nutraceutical Inc. shelling out $153.5 million to purchase the embattled diet bar maker's assets.

  • August 27, 2007

    Trasylol Continues To Cause Heartache For Bayer

    Bayer AG may soon face regulatory scrutiny over Trasylol, with the U.S. Food and Drug Administration set to hear testimony from a group of outside experts as to whether the blood-clotting drug can cause kidney damage, heart failure and even death.

  • August 24, 2007

    Depo-Provera Case Must Stay In Calif.: MDL Panel

    The Judicial Panel on Multidistrict Litigation has refused a request to centralize three cases filed against Pfizer, Inc. over its birth control product Depo-Provera, handing drug giant Pfizer a victory in the transfer dispute.

  • August 23, 2007

    MedPointe Sues Generics Maker Over Allergy Spray

    MedPointe Healthcare Inc. on Wednesday filed a patent infringement suit against Cobalt Pharmaceuticals Inc. in an attempt to stop the Canadian drug company from making a generic version of its anti-allergy medication.

  • August 23, 2007

    Dr. Can't Be Deposed In Defective Syringe Suit: Judge

    A federal judge handed a McKesson Corp. unit and Becton, Dickinson and Co. a setback Wednesday in a product liability suit that accuses them of manufacturing and distributing defective syringes.